Elliott D. Kieff, MD, PhD, Albee Professor of Medicine and of Microbiology and Immunology, Harvard University
Join us for a free 10x Genomics Seminar sponsored by UNC High Throughput Sequencing Facility (HTSF). The speaker will be Fran Moses.
This presentation of Cancer Transitions will be conducted in Spanish, and will runs from April 14 until May 19. Each weekly session lasts for 2 - 2 1/2 hours and includes information on nutrition, exercise, coping with stress, and medical care, plus delicious healthy snacks. This program is open to cancer patients who have completed treatment and their loved ones.
David B. Weiner, PhD, Wistar Institute Professor, Director of the Vaccines Centre & EVP, Wistar Insitute, Professor Emeritus, Department of Pathology and Laboratory Medicine, Chair, Gene Therapy and Vaccine Program, CAMB, Member, Abramson Cancer Program University of Pennsylvania, Perelman School of Medicine
Roger Lo, MD, PhD, Associate Professor of Medicine, Division of Dermatology and the Department of Molecular and Medical Pharmacology, University of California at Los Angeles
Cancer Transitions is a free program that runs for 4-6 weeks, beginning May 3, 2016. Each weekly session lasts for 2 - 2 1/2 hours and includes information on nutrition, exercise, coping with stress, and medical care, plus delicious healthy snacks. This program is open to cancer patients who have completed treatment and their loved ones.
Jason Cyster, Ph.D., UCSF School of Medicine
Hit for Cancer is a family event benefiting UNC Lineberger Comprehensive Cancer Center Immunotherapy Research. The event features cardio tennis for all ages and level and highlights the benefits of fitness for the patient, family and caregiver during the rigorous treatment, stress and recovery through the cancer journey.
Please join the UNC Cancer Network for an online, interactive telehealth lecture with Lyn Filip, RN, BSN, OCN. Participants can expect to learn more about the Human Papillomavirus (HPV) and its connection to cancer. Lunch and Learn lectures are geared toward cancer patients, survivors, and care givers/supports but anyone interested in learning more about cancer is welcome to join us.
Susan Slaugenhaupt, PhD, Center for Human Genetic Research, Massachusetts General Hospital Research Institute and Harvard Medical School